Sponsors
The bill expands naloxone access, training, education, and data-driven coordination to reduce school-area overdoses—especially in high-need communities—but relies on short-term grants and new reporting requirements that create administrative, privacy, and sustainability challenges for under-resourced and private schools.
Students and school staff in high-overdose areas will receive naloxone and related training and — when combined with mandatory reporting to NEMSIS/ODMAP — public-health and EMS responses will be faster and more informed, reducing overdose deaths and improving emergency outcomes.
Schools and local public-health agencies will gain better overdose trend data and must develop emergency response plans in coordination with health departments, improving local coordination and enabling more targeted prevention and resource deployment.
Students and communities will receive funded CPR, prevention, and overdose-response education, increasing lifesaving skills, awareness, and school/community preparedness.
Schools and local education agencies must complete new reporting and administrative requirements (including 90-day reports), imposing staff time and compliance burdens that strain under-resourced districts.
Grants are one-year awards and funding may be insufficient relative to need, so schools could lose access to naloxone, supplies, and training when grants end or some high-need schools may not receive support, leaving gaps in protection.
Reporting of overdose-reversal distributions and related data could raise privacy and confidentiality concerns for students and staff if data are not adequately de-identified or protected.
Based on analysis of 3 sections of legislative text.
Introduced March 19, 2026 by Raul Ruiz · Last progress March 19, 2026
Provides one-year competitive grants to private and public K–12 schools and local educational agencies to buy opioid overdose reversal drugs (e.g., naloxone) and to develop/implement emergency overdose response plans and related training. Requires covered schools and LEAs that receive federal funds to report any distribution of an overdose reversal drug to two national overdose surveillance systems within specified timelines and requires federal summary reporting to Congress.